Skawran, Stephan
Gennari, Antonio G.
Dittli, Manuel
Treyer, Valerie
Muehlematter, Urs J.
Maurer, Alexander
Burger, Irene A.
Mader, Cäcilia
Messerli, Olivia
Grünig, Hannes
Gebhard, Catherine
Huellner, Martin W.
Curioni-Fontecedro, Alessandra
Berger, Christoph
Messerli, Michael
Funding for this research was provided by:
GE Healthcare (unrelated to current study)
Article History
Received: 6 April 2021
Revised: 15 May 2021
Accepted: 2 June 2021
First Online: 22 June 2021
Declarations
:
: The scientific guarantor of this publication is Dr. Michael Messerli.
: Dr. Stephan Skawran is supported by a grant from the Palatin-Foundation, Switzerland. Dr. Michael Messerli and Dr. Irene Burger received a research grant from the Iten-Kohaut Foundation, Switzerland. Dr. Michael Messerli and Dr. Huellner are supported by a grant from the CRPP AI Oncological Imaging Network of the University of Zurich. Dr. Martin W. Huellner received grants from GE Healthcare and a fund by the Alfred and Annemarie von Sick legacy for translational and clinical cardiac and oncological research.
: No complex statistical methods were necessary for this paper.
: Written informed consent was obtained from all patients in this study.
: Institutional Review Board approval was obtained.
: • retrospective• observational study• performed at one institution